Aether Biomedical Announces Series A Funding Round Close, Pushes Forward Future of Upper Limb Prosthetics
Aether Biomedical, a biotech company creating cutting-edge bionic prosthetics, today announced the successful conclusion of a $5.8 Million Series A funding round, led by J2 Ventures and Story Ventures.
- Aether Biomedical, a biotech company creating cutting-edge bionic prosthetics, today announced the successful conclusion of a $5.8 Million Series A funding round, led by J2 Ventures and Story Ventures.
- “I founded Aether Biomedical with a resolute commitment to make bionics accessible for all people,” said Dhruv Agrawal, CEO and co-founder of Aether Biomedical.
- “The Zeus hand has unmatched intelligence and answers an unmet need in upper limb prosthetics.
- We know that upper limb amputees want stronger grips and less downtime if their prosthesis needs maintenance.